Core Insights - Pangea Natural Foods Inc. announces a strategic collaboration with Dr. Neal Davies and Dr. Raimar Loebenberg to enhance non-injectable peptide delivery systems for consumer wellness applications [1][5] Group 1: Collaboration Details - Amino Innovations, a subsidiary of Pangea, will leverage the expertise of two renowned pharmaceutical scientists to accelerate research and development [1][2] - The collaboration will utilize the University of Alberta's Drug Development and Innovation Centre for formulation and validation [2] Group 2: Research Scope - The partnership aims to establish benchmarks for precision peptide delivery across various formulations, including oral, dermal, and topical [3] - Research will focus on the absorption, bioavailability, and stability of peptides like BPC-157, GHK-Cu, and KPV, using natural enhancers [3][4] Group 3: Strategic Goals - The data generated will enhance Amino Innovations' intellectual property portfolio and regulatory credibility, facilitating new product development in nutraceutical and cosmeceutical markets [4] - The collaboration is expected to create scientific transparency in the wellness industry by generating pharmacokinetic and permeability data [5][6]

Core Points - Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company focused on developing products for chronic wound management, infertility, and cosmeceuticals for health and beauty [1][6] - The company will present at the Skyline Signature Series™ on October 8, 2025, at 11:00 AM ET, allowing investors to engage in real-time Q&A [1][2][3] Event Details - Event Name: Skyline Signature Series™ [3] - Date: October 8, 2025 [3] - Time: 11:00 AM ET [3] - Registration Link: https://us02web.zoom.us/webinar/register/WN_wWWf2nr8QZmKgzx7IaKrXA/registration [3] About Skyline Corporate Communications Group - Skyline Corporate Communications Group, LLC provides investor relations services and ensures a high-quality audience for public companies through careful vetting [4][5] - The firm has experience in strategic messaging and investor communications for public corporations across various industries [5]

Core Viewpoint - COSCIENS Biopharma Inc. has appointed Anna Biehn as the new Chief Executive Officer, effective May 5, 2025, succeeding Gilles Gagnon, who will remain as a Strategic Advisor and Director [1][3]. Company Overview - COSCIENS Biopharma Inc. is a life science company that develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical, and pharmaceutical products [5][6]. - The company focuses on leveraging proprietary extraction technology to produce active ingredients from renewable plant resources [5]. Leadership Transition - Anna Biehn brings over 25 years of experience in global general management and marketing, previously serving as Chief Financial Officer at NuTek Natural Ingredients [2][3]. - Gilles Gagnon has been with the company since 2008 and has played a key role in its growth and positioning [3]. Strategic Vision - The company aims to establish itself as a global leader in natural-based products for health and wellness, capitalizing on the growing demand for natural ingredients [3][4]. - Biehn expressed confidence in COSCIENS' portfolio and technology, highlighting significant innovation opportunities for both near-term and long-term value [3]. Market Position - COSCIENS is listed on both the Nasdaq Capital Market and the Toronto Stock Exchange under the ticker symbol "CSCI" [6].

As filed with the Securities and Exchange Commission on December 6, 2024 Registration No. 333-[ ] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cuprina Holdings (Cayman) Limited (Exact name of registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) Cayman Islands 5047 Not Applicable (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industria ...

As filed with the Securities and Exchange Commission on September 23, 2024 Registration No. 333-277731 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 9 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cuprina Holdings (Cayman) Limited (Exact name of registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (State or Other Jurisdiction of Incorporation or Organization) Cayman Islands 5047 Not Applicable (Pr ...

As filed with the Securities and Exchange Commission on September 19, 2024 Registration No. 333-277731 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 8 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cuprina Holdings (Cayman) Limited (Exact name of registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (State or Other Jurisdiction of Incorporation or Organization) Cayman Islands 5047 Not Applicable (Pr ...

As filed with the Securities and Exchange Commission on September 9, 2024 Registration No. 333-277731 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 6 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cuprina Holdings (Cayman) Limited (Exact name of registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (State or Other Jurisdiction of Incorporation or Organization) Cayman Islands 5047 Not Applicable (Pri ...

As filed with the Securities and Exchange Commission on September 3, 2024 Registration No. 333-277731 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 5 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cuprina Holdings (Cayman) Limited (Exact name of registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) Cayman Islands 5047 Not Applicable (State or Other Jurisdiction of Incorporation or Organization) (Pri ...

As filed with the Securities and Exchange Commission on June 20, 2024 Registration No. 333-277731 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cuprina Holdings (Cayman) Limited (Exact name of registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) Cayman Islands 5047 Not Applicable (State or Other Jurisdiction of Incorporation or Organization) (Primary ...

As filed with the Securities and Exchange Commission on May 15, 2024 Registration No. 333-277731 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cuprina Holdings (Cayman) Limited (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) c/o Blk 1090 Lower Delta Road #06-08 Singapore 169201 +65 8512 72 ...